Aurinia Pharmaceuticals Inc (AUPH)

[vidpok45]

That end of the day surge Friday might have been significant, we'll know soon enough. Lost, in researching the trials for uveitis, the molecule which was not approved at that point was subsequently modified to become the current version of Voclosporin. Did you read how the molecule was changed? I wonder if the company which eventually acquires AUPH will revisit that indication with the current version. I think Glickman was assigned the task of getting the investment community interested in the company in anticipation of a buyout. I just hope that management doesn't accept a lowball offer just to get it over with. Glickman managed to get 1 billion for Celcept which is inferior to Voclosporin. Voclosporin should fetch 2 billion or more I would guess. Monday should be interesting.